Delivery Order SPE2DE24D0013-SPE2D626F1857
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,179.30 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency) on May 2, 2025, with completion scheduled for May 9, 2025. The delivery order, designated 4568136320 ! XPCOV2/FLU/RSV-10, is for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing solutions and carries no set-aside designation. The work will be performed in Sunnyvale,...
- The Defense Department's Medical Supply Chain agency awarded a $1,540 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on September 3, 2025, with an ultimate completion date of September 10, 2025. The contract, designated XPRSARS-COV2-10, carries no set-aside designation and represents a delivery order likely issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,815 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 7, 2025, with ultimate completion targeted for August 21, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with one of Cepheid's existing Indefinite Delivery Vehicle contracts with...
- The U.S. Defense Medical Supply Chain awarded a $13.6K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 2, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order (Contract No. 4569302261) procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a continuation of...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 19, 2025, with an ultimate completion date of September 26, 2025. This delivery order, issued under contract XPRS4PLEX-10, carries no set-aside designation and represents a direct procurement of diagnostic solutions from a leading provider of molecular testing technologies. The award draws from...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $13,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. Issued on August 14, 2025, with an ultimate completion date of August 21, 2025, this delivery order (XPRS4PLEX-10) carries no set-aside designation and represents a short-term procurement under one of Cepheid's existing indefinite delivery vehicle contracts. The place of performance is Sunnyvale,...
- The U.S. Defense Department's Medical Supply Chain awarded a $204,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 22, 2025, and carries no set-aside designation. This award represents a continuation of the department's partnership with Cepheid to procure diagnostic testing solutions, specifically for...
- Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a $1,155.00 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency component) on September 16, 2025, with an ultimate completion date of September 23, 2025. This delivery order, designated XPRS-COV2-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The contract type and minimal ceiling value suggest this is a small, targeted...
- The U.S. Defense Department's Medical Supply Chain division awarded a $1,155 firm fixed-price delivery order to Cepheid Inc. on July 15, 2025, with an ultimate completion date of July 22, 2025. The contract, designated XPRSARS-COV2-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order represents a discrete procurement action for molecular diagnostic solutions, consistent with Cepheid's core business of manufacturing...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,930.72 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on May 2, 2025, with an ultimate completion date of May 9, 2025. The contract, designated as XPRSMVP-10, carries no set-aside designation and represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. Cepheid specializes in...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F1857Delivery Order
The U.S. Defense Department's Medical Supply Chain agency awarded a $3,850 delivery order (Contract No. XPRS-COV2-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on October 15, 2025, with an ultimate completion date of October 22, 2025, carries no set-aside designation. The award leverages Cepheid's established capability in providing molecular diagnostic testing systems and reagents, which the company has demonstrated through multiple existing federal contracts with the Department of Veterans Affairs and Defense Logistics Agency. This delivery order likely represents a continuation of Cepheid's ongoing support for COVID-19 and infectious disease diagnostics across federal healthcare systems. Cepheid operates under significant Indefinite Delivery Vehicle contracts with the VA, including a $32.8 million single-award IDV with Veterans Integrated Service Network 6 extending through September 2030 and a $2.5 million IDV with Veterans Integrated Service Network 21, both supporting PCR testing and molecular diagnostic reagents for conditions including COVID-19, influenza, respiratory syncytial virus, and tuberculosis. The modest ceiling value of this particular delivery order suggests it represents a discrete, near-term requirement within the broader diagnostic testing support Cepheid provides to federal defense and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 10/15/25 |